Forest Laboratories Inc.
909 Third Avenue
New York,
NY 10022-4731
United States - Map
Phone: 212-421-7850
Fax: 212-750-9152
Web Site: http://www.frx.com
| Forest Laboratories, Inc. develops, manufactures, and sells branded and generic forms of ethical drug products. Its principal products include Lexapro to treat depression; Namenda to treat Alzheimer's disease; Bystolic, beta-blocker to treat hypertension; and Savella for the treatment of fibromyalgia. The company also provides Sudocrem, a topical preparation to treat diaper rash; Colomycin, an antibiotic to treat cystic fibrosis; Infacol, which is used to treat infant colic; and Exorex, which is to treat eczema and psoriasis. In addition, its products include Dutogliptin, a small molecule dipeptidyl-peptidase-4 inhibitor, which is in Phase III studies to treat Type II diabetes mellitus; F2695 that completed Phase II study and is a selective norepinephrine and serotonin reuptake inhibitor for the treatment of depression and other central nervous system disorders; and ceftaroline acetate, a injectable cephalosporin antibiotic that exhibits bactericidal activity against the strains of gram-positive bacteria. Further, the companys products comprise NXL104, an intravenous beta-lactamase inhibitor; Linaclotide for the treatment of constipation-predominant irritable bowel syndrome and chronic constipation; Aclidinium, an inhaling therapy, which is in Phase III studies for chronic obstructive pulmonary disease; and Cariprazine, an atypical antipsychotic in Phase II(b) studies for the treatment of schizophrenia, bipolar mania, and other psychiatric conditions. Additionally, its products include Oglemilast, a phosphodiesterase-IV inhibitor in Phase II study to treat COPD and asthma; and Benicar, an angiotensin receptor blocker to treat hypertension. The company has collaboration and license agreements Phenomix Corporation, Pierre Fabre Medicament, Novexel, S.A., Laboratorios Almirall, S.A., Gedeon Richter Ltd., Glenmark Pharmaceuticals Ltd., and AstraZeneca plc. Forest Laboratories, Inc. was founded in 1956 and is based in New York, New York. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Howard Solomon , 82
Chairman and Chief Exec. Officer |
$
1.92M |
$
7.32M | Dr. Lawrence S. Olanoff M.D., Ph.D., 58
Pres, Chief Operating Officer, Director, Chairman of Compliance Committee and Member of Disclosure, Legal Compliance & Risk Management Committee |
$
1.24M |
$
0 | Mr. Francis I. Perier Jr., 50
Chief Financial Officer, Principal Accounting Officer, Sr. VP of Fin. and Member of Disclosure, Legal Compliance & Risk Management Committee |
$
824.00K |
$
0 | Ms. Elaine Hochberg , 53
Chief Commercial Officer, Sr. VP of Marketing and Member of Disclosure, Legal Compliance & Risk Management Committee |
$
892.00K |
$
0 | Mr. William J. Candee III, 83
Sec., Independent Director, Chairman of Nominating & Governance Committee, Chairman of Audit Committee and Member of Compensation Committee |
$
65.00K | N/A |
|
|
|
Dollar amounts are as of
31-Dec-09
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.52% Nasdaq 0.00%
Profile
